Antimicrobial Resistance and Antimicrobial Therapy of Clinically Relevant Bacteria

Georgios Meletis, Lemonia Skoura and Efthymia Protonotariou

antimicrobial resistance mechanisms; antimicrobial resistance detection; antimicrobial resistance epidemiology; antimicrobial treatment; new antibiotics; MDR; Klebsiella pneumoniae; Acinetobacter baumannii; Pseudomonas aeruginosa; MRSA;

Antimicrobial resistance is a public health problem of major importance, and the World Health Organization (WHO) has warned that the current antibiotic armamentarium is not sufficient to face future challenges. The antibiotic pipeline is not providing new compounds at a sufficient speed for various reasons, and thus, few novel drugs have reached clinical practice lately; old, formerly abandoned antimicrobials are increasingly used as last-resort treatment options. At this pace, untreatable infec

journal Antibiotics

2025

file

pdf

978-3-7258-6078-4

https://doi.org/10.3390/books978-3-7258-6078-4

Eng

https://creativecommons.org/licenses/by-nc-nd/4.0/

Pharmacy